These grants will help us push the boundaries of cancer research and better understand metastatic processes, always with patients as our #1 priority.
Thank you for believing in our science and our vision!!
#LiU #CancerResearch

“Multimodal analysis of systemic effects in gastrointestinal cancer for relapse prediction and individualized treatment – focusing on extracellular vesicles and pre-metastatic niches.” and "From organ to whole body: scaling up ex vivo cancer metabolism with digital twins.”

In other words, from pre-metastatic niche formation to overt metastasis. A key aim of his work is to translate these biological insights into improved strategies for the prevention and treatment of recurrence.

#CancerResearch #Metastasis #TranslationalResearch

His passion for pancreatic cancer began in clinical work, and now continues his research at the Department of Clinical Pathology, Linköping University Hospital. Off‑lab, he loves hiking and climbing.
#PancreaticCancer #Pathology

She joined the Bojmar group in 2022 and leads the collection and processing of patient materials: essential to projects on EV biomarkers and the pre‑metastatic niche. Outside of work, she enjoys kayaking, gardening and arts.
#ResearchEngineer #Premetastatic #Biomaterials #CancerResearch

He emphasizes the power of large collaborative networks to address clinical challenges and integrates closely with the Bojmar Lab’s translational work.
#SurgicalOncology #TranslationalResearch #HPBsurgery

He has led extensive clinical, registry-based, and international studies to improve diagnostics, evaluate therapies, and optimize patient selection.
#HPBCancer #PancreaticCancer #HepatobiliarySurgery #ClinicalResearch #TranslationalResearch

His research integrates stable isotope tracing, mass spectrometry, and systems biology to increase translational relevance while reducing animal use. #CancerMetabolism #SystemsBiology #TranslationalResearch #MetabolicReprogramming

With deep expertise in protein chemistry, biophysics and EV technology, he now drives method development, managing key EV instruments, expanding isolation pipelines, and leading the local EV network at LiU.
#EVResearch #CancerMetastasis #PreMetastaticNiche

She works clinically in pediatric oncology and within the Bojmar group she studies cancer‑derived extracellular vesicles and the immunological aspect of the pre-metastatic niche.
#PediatricOncology #CancerResearch

Now he focuses on immune‑mediated mechanisms, radiomic/molecular profiling, and personalized treatment tailoring.
#SurgeonScientist #PancreaticCancer #PrecisionOncology

She joined the Bojmar group in fall 2024 to study portal biomarkers in gastrointestinal cancers, particularly pancreatic cancer, and their clinical applications.
#SurgeontoBe #PortalBiomarkers #ResearchJourney

He’s now surgical consultant and PhD investigating risk factors and outcomes of colorectal cancer in younger patients. His collaboration with the Bojmar Lab began in 2022.
#ColorectalCancer #SurgicalOncology #ClinicalResearch